Predictors of Pegylated Interferone Treatment Response In HBeAg Negative Chronic Hepatitis B

被引：0
|
作者：
Guclu, Ertugrul [1 ]
Tuna, Nazan [1 ]
Karabay, Oguz [1 ]
机构：
[1] Sakarya Univ, Dept Infect Dis & Clin Microbiol, Minist Hlth, Training & Res Hosp, Sakarya, Turkey
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
452
引用
收藏
页码：414A / 415A
页数：2
相关论文
共 50 条
  • [1] Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
    Guclu, Ertugrul
    Tuna, Nazan
    Karabay, Oguz
    Akhan, Sila
    Bodur, Hurrem
    Ceylan, Bahadir
    Demirdal, Tuna
    Demirdag, Kutbettin
    Demirturk, Nese
    Ekerbicer, Hasan
    Erol, Serpil
    Esen, Saban
    Evirgen, Omer
    Geyik, Mehmet Faruk
    Gunduz, Alper
    Karahocagil, Mustafa Kasim
    Kokoglu, Omer Faruk
    Ozdemir, Davut
    Ozgunes, Nail
    Sargin, Fatma
    Tosun, Selma
    Tutuncu, Ediz
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (12): : 1601 - 1608
  • [2] Treatment of HBeAg-negative chronic hepatitis B with pegylated interferon
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2011, 31 : 90 - 94
  • [3] Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon
    Brunetto, MR
    Oliveri, F
    Colombatto, P
    Coco, B
    Ciccorossi, P
    Bonino, F
    JOURNAL OF HEPATOLOGY, 2003, 39 : S164 - S167
  • [4] Response predictors to treatment with pegylated interferon in chronic hepatitis B
    Abrao Ferreira, Paulo Roberto
    Tenore, Simone de Barros
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (05): : 519 - 525
  • [5] Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
    Farag, Mina S.
    van Campenhout, Margo J. H.
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    van Vuuren, Anneke J.
    Ferenci, Peter
    Feld, Jordan J.
    Berg, Thomas
    Hansen, Bettina E.
    van Bommel, Florian
    Janssen, Harry L. A.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 202 - 211
  • [6] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [7] Response to extended lamivudine treatment of HBeAg negative chronic hepatitis B.
    Andreone, P
    Hussain, MT
    Lok, AS
    Gramenzi, A
    Cursaro, C
    Lorenzini, S
    Porzio, F
    Margotti, M
    HEPATOLOGY, 2001, 34 (04) : 321A - 321A
  • [8] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Alizadeh, Amir Houshang Mohammad
    Ranjbar, Mitra
    Karimi, Babak
    Hatami, Saeed
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (26) : 4203 - 4205
  • [9] Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran
    Amir Houshang Mohammad Alizadeh
    Mitra Ranjbar
    Babak Karimi
    Saeed Hatami
    World Journal of Gastroenterology, 2006, (26) : 4203 - 4205
  • [10] Combination treatment in HBeAg-negative chronic hepatitis B
    Tziomalos, Konstantinos
    WORLD JOURNAL OF HEPATOLOGY, 2009, 1 (01) : 43 - 47
12345